Browse studies

Find your next paid study

103 recruiting studies matching your filters

Accurate Point of Care Liver Disease Diagnostics

This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. This is the second phase of a project in whi…

MASLDMASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)NAFLD+1 more

Estimated

~$10 – $750

University of California, San DiegoNCT07518784

Observational

Feasibility and Acceptability of a Novel Implementation Intervention to Promote Alcohol Use Disorder Treatment in Hepatology Clinics

The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use …

Alcohol Use DisorderAlcohol-associated Liver Disease

Estimated

~$10 – $6,250

Yale UniversityNCT07525258

Phase 1

A Three-Part, Phase 1/2a, Randomized, Double-blind, Placebo-Controlled, Single and Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of ALN-PNP, an siRNA Targeting PNPLA3, in Healthy Adults and Adult Participants With MASLD

This study is researching an experimental drug called ALN-PNP (called "study drug"). This is a first in human study. The study drug is not approved by any publ…

Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Estimated

~$10 – $8,750

Regeneron PharmaceuticalsNCT05648214

Phase 2

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety o…

Non-Alcoholic Fatty Liver DiseaseNAFLDPediatric NAFLD

Estimated

~$10 – $7,500

Justin RyderNCT03867487

Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) Study 2.0 - An FNIH Biomarkers Consortium Study

The Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) study is a comprehensive, multi-year collaborative effort to standardize, validate and advance…

Metabolic Associated Fatty Liver DiseaseMetabolic Associated Steatotic Liver DiseaseCirrhosis, Liver+5 more

Estimated

~$10 – $675

Foundation for the National Institutes of HealthNCT07122700

A Multi-Center, Longitudinal Study of Drug-and CAM-Induced Liver Injury

The purpose of this study is to identify individuals who have suffered a liver injury arising as an idiosyncratic reaction to a prescription drug or a compleme…

Liver Diseases

Estimated

~$10 – $750

Duke UniversityNCT00345930

Observational

A Single Center, Non-randomized Study to Evaluate the Safety and Efficacy of Left Gastric Artery Embolization, to Promote Short-term Weight Loss in Obese Patients With Nonalcoholic Steatohepatitis (NASH) and Thereby Improve NASH

Obesity is an epidemic in the US. With progression of obesity, Nonalcoholic steatohepatitis (NASH) has been a growing public health issue. Presently there is n…

ObesityWeight LossBody Weight+3 more

Estimated

~$10 – $7,500

Keith Pereira, MD:NCT02933554

Endoscopic Ultrasound With Shear Wave Elastography for the Assessment of Liver Disease

This study shall be a prospective, multicenter, single arm, consecutive, interventional study conducted in a post-market setting using commercially available d…

MASLDMASHFibrosis, Liver+1 more

Estimated

~$10 – $1,050

Olympus Corporation of the AmericasNCT06592820

Thermoacoustic Method for Estimating Liver Fat Fraction - Pilot Study I

The goal of this study is to use our Thermoacoustic Enhanced Ultrasound device to measure the fat levels in your liver and compare it to the the gold standard …

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Fatty Liver Disease, Nonalcoholic

Estimated

~$10 – $1,125

Endra LifesciencesNCT07321925

Observational

The Olmsted NAFLD Epidemiology Study (TONES)

Researchers are assessing the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in the population and assembling …

Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic Steatohepatitis

Estimated

~$10 – $6,250

Mayo ClinicNCT04365855

Observational

Pilot Study of Time-Restricted, Intermittent Fasting for Non-Alcoholic Fatty Liver Disease in Non-Obese Adults

NAFLD is a growing threat to public health. Currently, there is a significant need for highly effective treatments for NAFLD. Non-obese NAFLD (BMI\<30kg/m2) is…

Fatty LiverIntermittent FastingFatty Liver, Nonalcoholic+2 more

Estimated

~$10 – $6,250

Massachusetts General HospitalNCT04899102

Phase 2

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety o…

Non-Alcoholic Fatty Liver Disease

Estimated

~$10 – $7,500

Justin RyderNCT06355310